FACTANKER · measured, cited, anchored official records connected

PHARMACYTE BIOTECH, INC. — Revenue by Fiscal Year

16 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/827ea70a-a31c-493b-8e14-915d40c96135/serie/revenue

Fiscal yearRevenuePeriodEvidence
FY 2025$02025-05-01 – 2026-04-30evidence 0001683168-26-005836
FY 2024$02024-05-01 – 2025-04-30evidence 0001683168-25-005821
FY 2023$02023-05-01 – 2024-04-30evidence 0001683168-24-005575
FY 2022$02022-05-01 – 2023-04-30evidence 0001683168-23-005175
FY 2021$02021-05-01 – 2022-04-30evidence 0001683168-22-005189
FY 2020$02020-05-01 – 2021-04-30evidence 0001683168-21-003377
FY 2019$02019-05-01 – 2020-04-30evidence 0001683168-20-002680
FY 2018$02018-05-01 – 2019-04-30evidence 0001683168-19-002559
FY 2017$02017-05-01 – 2018-04-30evidence 0001683168-18-001994
FY 2016$02016-05-01 – 2017-04-30evidence 0001683168-17-001881
FY 2015$02015-05-01 – 2016-04-30evidence 0001019687-16-007057
FY 2014$02014-05-01 – 2015-04-30evidence 0001019687-16-007057
FY 2013$02013-05-01 – 2014-04-30evidence 0001019687-16-007057
FY 2012$12.2k2012-05-01 – 2013-04-30evidence 0001157075-13-000010
FY 2011$66.6k2011-05-01 – 2012-04-30evidence 0001262463-12-000335
FY 2010$76.0k2010-05-01 – 2011-04-30evidence 0001262463-12-000335
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

PHARMACYTE BIOTECH, INC. — all facts · Net Income · Operating Income